CRCT(CRCT)
CRCT
$5.67—Stale · unknown old
NASDAQ • Last print unknown ago
$5.67—Stale · unknown old
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $697M | $705M | $715M |
| Low | $696M | $704M | $715M |
| High | $697M | $705M | $715M |
| EBITDA Avg | $131M | $96M | $98M |
| Low | $131M | $96M | $98M |
| High | $131M | $96M | $99M |
| EBIT Avg | $107M | $73M | $75M |
| Low | $107M | $73M | $75M |
| High | $107M | $73M | $75M |
| Net Income Avg | $76M | $51M | $53M |
| Low | $76M | $51M | $53M |
| High | $76M | $51M | $53M |
| EPS Avg | $0.35 | $0.24 | $0.24 |
| Low | $0.35 | $0.24 | $0.24 |
| High | $0.35 | $0.24 | $0.25 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $172M | $209M | $158M | $157M | $192M | $200M |
| Low | $172M | $209M | $158M | $157M | $192M | $200M |
| High | $172M | $209M | $158M | $157M | $192M | $200M |
| EBITDA Avg | $20M | $13M | $26M | $31M | $22M | $12M |
| Low | $20M | $13M | $26M | $31M | $22M | $12M |
| High | $20M | $13M | $26M | $31M | $22M | $12M |
| EBIT Avg | $14M | $7M | $19M | $25M | $16M | $6M |
| Low | $14M | $7M | $19M | $25M | $16M | $6M |
| High | $14M | $7M | $19M | $25M | $16M | $6M |
| Net Income Avg | $10M | $5M | $14M | $18M | $12M | $4M |
| Low | $10M | $5M | $14M | $18M | $12M | $4M |
| High | $10M | $5M | $14M | $18M | $12M | $4M |
| EPS Avg | $0.05 | $0.02 | $0.07 | $0.08 | $0.06 | $0.02 |
| Low | $0.05 | $0.02 | $0.07 | $0.08 | $0.06 | $0.02 |
| High | $0.05 | $0.02 | $0.07 | $0.08 | $0.06 | $0.02 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |